The Relationship Among Atrium Electromechanical Interval, Insulin Resistance, and Metabolic Syndrome

Canadian Journal of Cardiology

Volumn 29, Issue 10, 2013, Pages 1263-1268

  Hung, Chung Lieh ^a,b   Chao, Tze Fan ^c,d   Lai, Yau Huei ^a,b   Yen, Chih Hsuan ^a,b   Wang, Kang Ling ^c,d   Tsao, Hsuan Ming ^d   Lin, Yenn Jiang ^c,d   Chang, Shih Lin ^c,d   Lo, Li Wei ^c,d   Hu, Yu Feng ^c,d   Kuo, Jen Yuan ^a,b   Yeh, Hung I ^a,b   Chen, Shih Ann ^c,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; IMMUNOREACTIVE INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEART ATRIUM CONDUCTION; HEART ATRIUM ELECTROMECHANICAL INTERVAL; HEART CYCLE; HEART LEFT ATRIUM; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; P WAVE; RETROSPECTIVE STUDY; TRANSTHORACIC ECHOCARDIOGRAPHY; WAIST CIRCUMFERENCE;

ATRIAL FIBRILLATION; ATRIAL FUNCTION; ATRIAL REMODELING; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART RATE; HUMANS; INCIDENCE; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84884588915     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.01.001     Document Type: Article

References (23)

1. Mottillo S., Filion K.B., Genest J., et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. JAm Coll Cardiol 2010, 56:1113-1132.
2. Watanabe H., Tanabe N., Watanabe T., et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008, 117:1255-1260.
3. Tang R.B., Dong J.Z., Liu X.P., et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2009, 73:438-443.
4. Chang S.L., Tuan T.C., Tai C.T., et al. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am J Cardiol 2009, 103:67-72.
5. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003, 107:391-397.
6. Ford E.S., Mokdad A.H., Giles W.H., Brown D.W. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003, 52:2346-2352.
7. Liu T., Li G., Li L., Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. JAm Coll Cardiol 2007, 49:1642-1648.
8. Korantzopoulos P., Kolettis T.M., Galaris D., Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007, 115:135-143.
9. Merckx K.L., De Vos C.B., Palmans A., et al. Atrial activation time determined by transthoracic Doppler tissue imaging can be used as an estimate of the total duration of atrial electrical activation. JAm Soc Echocardiogr 2005, 18:940-944.
10. Chao T.F., Sung S.H., Wang K.L., et al. Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart 2011, 97:225-230.
11. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection.
12. Douglas P.S., Khandheria B., Stainback R.F., et al. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance. Endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. JAm Soc Echocardiogr 2007, 20:787-805.
13. Cuspidi C., Meani S., Fusi V., et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study. JHypertens 2005, 23:875-882.
14. Frohlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000, 23:1835-1839.
15. Dagres N., Anastasiou-Nana M. Atrial fibrillation and obesity an association of increasing importance. JAm Coll Cardiol 2010, 55:2328-2329.
16. Dublin S., Glazer N.L., Smith N.L., et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. JGen Intern Med 2010, 25:853-858.
17. De Vos C.B., Weijs B., Crijns H.J., et al. Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation. Heart 2009, 95:835-840.
18. Chiang C.E., Naditch-Brule L., Murin J., et al. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol 2012, 5:632-639.
19. Lau D.H., Mackenzie L., Kelly D.J., et al. Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model. Heart Rhythm 2010, 7:396-404.
20. Lau D.H., Mackenzie L., Kelly D.J., et al. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Heart Rhythm 2010, 7:1282-1290.
21. Akoum N., Daccarett M., McGann C., et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. JCardiovasc Electrophysiol 2011, 22:16-22.
22. Daccarett M., Badger T.J., Akoum N., et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. JAm Coll Cardiol 2011, 57:831-838.
23. Chao T.F., Sung S.H., Wang K.L., et al. Atrial electromechanical interval can identify patients with paroxysmal atrial fibrillation and is associated with CHADS2 score and peak velocity of left atrial appendage. JCardiovasc Electrophysiol 2011, 22:1325-1330.